Access brought to you by: LOCKSS

Oncology Clinical Trials

Goserelin Improves Ovarian Function in Premenopausal Women with Estrogen Receptor-Negative/Progesterone Receptor-Negative Breast Cancer
CRT with Oxaliplatin Improves DFS in Locally Advanced Rectal Cancer
Safety and Efficacy of Enzalutamide in Men with Metastatic Prostate Cancer: The PREVAIL Trial
Lenvatinib Improves Progression-Free Survival in Refractory Thyroid Cancer
Docetaxel at Beginning of Androgen Deprivation Therapy Boosts Overall Survival by over 1 Year
Ramucirumab Improves Survival in Stage IV NSCLC
Paclitaxel plus Bevacizumab is a Feasible Option for Chemoresistant SCLC
No Survival Advantage to Using Bevacizumab as First-Line Therapy for Glioblastoma
Antiangiogenesis Therapy with Bevacizumab Improves Survival in Metastatic or Relapsed Cervical Cancer
Nintedanib Plus Docetaxel Improves PFS and OS for Patients with Stage IIIB/IV or Recurrent Lung Adenocarcinoma

Pages